S100B and Parkinson disease: S100β was markedly increased by 77% after acute brain injury induced in the serum of PD rats when compared to the control group rats While S100β levels in the TNG 50 and 100 mg treatment groups were significantly (p < 0.05) lowered by 26 and 39% respectively, as compared to PD treated group.